Stephen Chen
November 3 2019
- Clinical trial shows effectiveness in treating mild to moderate forms of the disease, and it may even improve cognitive function
- Researchers noticed elderly people who regularly eat seaweed are less likely to develop the condition
The world’s first new drug for the treatment of Alzheimer’s disease in nearly two decades – and perhaps the only treatment with the potential to reverse the condition – was approved by the Chinese government on Saturday night.The National Medical Products Administration said the drug, Oligomannate, had been approved for the treatment of “mild to moderate Alzheimer’s disease and improving cognitive function”.
ws/china/science/article/3036119/china-approves-oligomannate-worlds-first-new-alzheimers-drug-20